Participated · Seed · Mar 2026

Niv-AI has developed an AI platform that links electricity consumption to computing workloads, aiming to help data centers use power more efficiently. The company's technology matches computing tasks with available electrical capacity to optimize energy use. Public reporting on the company centers on its recent Seed raise and investor syndicate rather than operational metrics. There are no reported revenue, user, or other key operating figures in the articles. The company raised $12 million in Seed funding to support its next stage of development. Additional details on future product plans or specific go-to-market initiatives were not disclosed in the coverage.

Participated · Series A · Nov 2024

MetaSight Diagnostics builds multi-omics screening and diagnostic products using a high-throughput, mass spectrometry–based discovery engine that integrates metabolomics, lipidomics and proteomics. The company claims the world’s largest serum metabolomics dataset linked to longitudinal electronic medical records and uses that dataset to identify diagnostic signatures at population scale. Its core programs target diseases including colorectal cancer (CRC) and metabolic dysfunction‑associated steatohepatitis (MASH). MetaSight plans to advance existing programs into FDA trials and expand its portfolio of diagnostic products. The company intends to make its tests available in selected markets in 2025 and is engaging in strategic partnerships to support commercialization. MetaSight was founded in 2021 and is headquartered in Rehovot, Israel. The Series A will fund pipeline development and additional strategic collaborations.